Shintaro Shichinohe

发表

Selection of antigenic variants of an H5N1 highly pathogenic avian influenza virus in vaccinated chickens.

Tatsuya Nishi, Y. Sakoda, H. Kida, 2017, Virology.

Potency of an inactivated influenza vaccine prepared from a non-pathogenic H5N1 virus against a challenge with antigenically drifted highly pathogenic avian influenza viruses in chickens.

T. Honda, Y. Sakoda, H. Kida, 2013, Veterinary microbiology.

Reintroduction of H5N1 highly pathogenic avian influenza virus by migratory water birds, causing poultry outbreaks in the 2010-2011 winter season in Japan.

A. Takada, Y. Sunden, Y. Sakoda, 2012, The Journal of general virology.

Instructions for use Title Protective Efficacy of Passive Immunization with Monoclonal Antibodies in Animal Models of H 5 N 1 HighlyPathogenic Avian Influenza Virus Infection

Y. Kawaoka, A. Takada, Y. Sakoda, 2018 .

Protective Efficacy of Passive Immunization with Monoclonal Antibodies in Animal Models of H5N1 Highly Pathogenic Avian Influenza Virus Infection

Y. Kawaoka, A. Takada, Y. Sakoda, 2014, PLoS pathogens.

SARS-CoV-2 infection triggers paracrine senescence and leads to a sustained senescence-associated inflammatory response

Tokiko Watanabe, Masahiro Yamamoto, Shintaro Sato, 2022, Nature Aging.

Experimental infection of highly and low pathogenic avian influenza viruses to chickens, ducks, tree sparrows, jungle crows, and black rats for the evaluation of their roles in virus transmission.

Tatsuya Nishi, Y. Sakoda, H. Kida, 2016, Veterinary microbiology.

Comparison of pathogenicities of H7 avian influenza viruses via intranasal and conjunctival inoculation in cynomolgus macaques.

Y. Sakoda, H. Kida, M. Okamatsu, 2016, Virology.

Sensitization with vaccinia virus encoding H5N1 hemagglutinin restores immune potential against H5N1 influenza virus

M. Kohara, K. Munekata, Y. Sakoda, 2016, Scientific Reports.

Pathogenicity of Pandemic H1N1 Influenza A Virus in Immunocompromised Cynomolgus Macaques

Y. Sakoda, H. Kida, M. Okamatsu, 2013, PloS one.

Protection against H5N1 Highly Pathogenic Avian and Pandemic (H1N1) 2009 Influenza Virus Infection in Cynomolgus Monkeys by an Inactivated H5N1 Whole Particle Vaccine

Y. Kawaoka, Y. Sakoda, H. Kida, 2013, PloS one.

Low replicative fitness of neuraminidase inhibitor-resistant H7N9 avian influenza A virus with R292K substitution in neuraminidase in cynomolgus macaques compared with I222T substitution.

Y. Sakoda, H. Kida, M. Okamatsu, 2020, Antiviral research.

Efficacy of clarithromycin against H5N1 and H7N9 avian influenza a virus infection in cynomolgus monkeys.

Y. Kawaoka, M. Le, Takeshi Shimizu, 2019, Antiviral research.

Potential risk of repeated nasal vaccination that induces allergic reaction with mucosal IgE and airway eosinophilic infiltration in cynomolgus macaques infected with H5N1 highly pathogenic avian influenza virus.

Y. Kawaoka, Y. Sakoda, H. Kida, 2017, Vaccine.

Inactivated whole influenza virus particle vaccines induce neutralizing antibodies with an increase in immunoglobulin gene subclones of B-lymphocytes in cynomolgus macaques.

Kimihito Ito, J. Yamagishi, H. Kida, 2022, Vaccine.

Potency of an inactivated influenza vaccine prepared from A/duck/Mongolia/119/2008 (H7N9) against the challenge with A/Anhui/1/2013 (H7N9).

Tatsuya Nishi, Y. Sakoda, H. Kida, 2014, Vaccine.

Efficacy of Repeated Intravenous Administration of Peramivir against Highly Pathogenic Avian Influenza A (H5N1) Virus in Cynomolgus Macaques

Y. Kawaoka, Q. M. Le, R. Yoshida, 2014, Antimicrobial Agents and Chemotherapy.

Genetic and antigenic characterization of H5 and H7 influenza viruses isolated from migratory water birds in Hokkaido, Japan and Mongolia from 2010 to 2014

A. Takada, H. Ogawa, Y. Sakoda, 2015, Virus Genes.

Genomic diversity of SARS-CoV-2 can be accelerated by mutations in the nsp14 gene

Tokiko Watanabe, Y. Matsuura, C. Ono, 2020, bioRxiv.

Characterization of H7N9 influenza A viruses isolated from humans

Noriko Kishida, Ryan McBride, Amie J. Eisfeld, 2013, Nature.

Macrocyclic peptides exhibit antiviral effects against influenza virus HA and prevent pneumonia in animal models

T. Katoh, Y. Kawaoka, M. Kohara, 2021, Nature Communications.

Selection of H3 avian influenza viruses with SAα2,6Gal receptor specificity in pigs.

Y. Sakoda, H. Kida, M. Okamatsu, 2013, Virology.

Emergence of H7N9 Influenza A Virus Resistant to Neuraminidase Inhibitors in Nonhuman Primates

Y. Sakoda, H. Kida, M. Okamatsu, 2015, Antimicrobial Agents and Chemotherapy.

Advances in Adjuvanted Influenza Vaccines

Tokiko Watanabe, Shintaro Shichinohe, 2023, Vaccines.

Selection of H3 avian influenza viruses with SAα2,6Gal receptor specificity in pigs.

Y. Sakoda, H. Kida, M. Okamatsu, 2013, Virology.